.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Covington
Baxter
Federal Trade Commission
Cipla
Moodys
Chinese Patent Office
Deloitte
Merck

Generated: November 18, 2017

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Cleocin, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries and six supplementary protection certificates in six countries.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
CLEOCIN
clindamycin hydrochloride
CAPSULE;ORAL061809-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
LOTION;TOPICAL050600-001May 31, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
CREAM;VAGINAL050680-001Aug 11, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
SWAB;TOPICAL050537-002Feb 22, 1994ATRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION062803-001Oct 16, 1987APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
SOLUTION;TOPICAL050537-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
CREAM;VAGINAL050680-002Mar 2, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
GEL;TOPICAL050615-001Jan 7, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
clindamycin phosphate
INJECTABLE;INJECTION050639-002Aug 30, 1989APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION050441-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CLEOCIN

Country Document Number Estimated Expiration
MexicoPA02001320► Subscribe
Portugal1200065► Subscribe
Morocco26749► Subscribe
TaiwanI232111► Subscribe
Austria250408► Subscribe
China1160056► Subscribe
Australia6219800► Subscribe
Slovenia1200065► Subscribe
China1360495► Subscribe
World Intellectual Property Organization (WIPO)0110407► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CLEOCIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Accenture
Julphar
Boehringer Ingelheim
US Department of Justice
Fish and Richardson
Queensland Health
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot